Once-monthly oral ibandronate (boniva) has favorable safety and tolerability in postmenopausal women with osteoporosis: 2-year results from MOBILE.

被引：0
|
作者：
Greenwald, M
Hawker, G
Cooper, C
Hughes, C
Mairon, N
Bonvoisin, B
Silverman, S
机构：
[1] Desert Med Adv, Palm Desert, CA USA
[2] Sunnybrook & Womens Coll Hosp, Toronto, ON, Canada
[3] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO9 5NH, Hants, England
[4] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland
[5] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] Once-monthly and daily oral ibandronate are at least as effective in improving proximal femur BMD in postmenopausal osteoporosis: 12-month data from MOBILE
    Reginster, JY
    Lorenc, R
    Stepan, JJ
    Hughes, C
    Mairon, N
    Bonvoisin, B
    Cooper, C
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 93 - +
  • [42] QCT and FEA Assessment of Proximal Femur Bone Quality and Strength in Women with Postmenopausal Osteoporosis Receiving Once-Monthly Oral Ibandronate for 12 Months
    Kivitz, A.
    Keaveny, T. M.
    Genant, H. K.
    Engelke, K.
    Fuerst, T.
    Kopperdahl, D.
    Fries, M.
    Dasic, G.
    Fitzpatrick, L. A.
    Lewiecki, E. M.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S230 - S230
  • [43] Renal tolerability profile of intermittent intravenous ibandronate injections in postmenopausal women with osteoporosis: DIVA 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S125 - S125
  • [44] Once-monthly ibandronate dosing is more effective than daily dosing for improving bone mineral density: Mobile 2-year analysis
    不详
    CALCIFIED TISSUE INTERNATIONAL, 2006, 78 : S160 - S161
  • [45] Favourable renal safety and tolerability profile of intravenous ibandronate injections in women with postmenopausal osteoporosis: 1-year results from diva
    Reid, DM
    Felsenberg, D
    Christiansen, C
    Leigh, C
    Ward, P
    Sedarati, F
    Delmas, PD
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 365 - 365
  • [46] Favorable renal safety profile of intravenous ibandronate injections in postmenopausal osteoporosis: 1-year results from DIVA
    Delmas, P
    Reid, D
    Felsenberg, D
    Leigh, C
    Ward, P
    Sedarati, F
    Christiansen, C
    BONE, 2005, 36 : S419 - S420
  • [47] Intermittent intravenous ibandronate injections are an effective treatment option in postmenopausal osteoporosis: 2-year results from diva
    Eisman, J. A.
    Garcia-Hernandez, P. A.
    Ortiz-Luna, G.
    Ste-Marie, L. G.
    Hughes, C.
    Mairon, N.
    Masanauskaite, D.
    Delmas, P. D.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S212 - S212
  • [48] A CANDIDATE INDENTIFICATION QUESTIONNAIRE FOR PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS SWITCHED FROM TREATMENT WITH A DIALY OR WEEKLY BISHPOSPHONATE TO ONCE-MONTHLY IBANDRONATE-BONCURE: RESULTS OF TURKISH SUB-STUDY
    Eskiyurt, Nurten
    Sendur, Omer Faruk
    Yalcin, Peyman
    Oncel, Sema
    Saridogan, Merih
    Sarpel, Tunay
    Tosun, Mehmet
    Kutsal, Yesim Gokce
    Senel, Kazim
    Gursoy, Savas
    Canturk, Ferhan
    Irdesel, Jale
    Demir, Huseyin
    Ozdener, Fatih
    Oncel, Hakan
    Serpici, Vesile
    Ugurlu, Hatice
    Kirazli, Yesim
    Ardic, Fusun
    Butun, Bulent
    Akyuz, Gulseren
    Cerrahoglu, Lale
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 198 - 198
  • [49] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial
    Adachi, J. D.
    Chesnut, C. H.
    Brown, J. P.
    Christiansen, C.
    Russo, L. A.
    Fernandes, C. E.
    Menegoci, J. C.
    Kung, A.
    Chines, A. A.
    Bessac, L.
    Chakrabarti, D.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S460 - S460
  • [50] Safety and tolerability of bazedoxifene in postmenopausal women with osteoporosis: Results from a 3-year, randomized, placebo- and active-controlled clinical trial
    Adachi, J. D.
    Chesnut, C. H.
    Brown, J. P.
    Christiansen, C.
    Russo, L. A.
    Fernandes, C. E.
    Menegoci, J. C.
    Kung, A.
    Chines, A. A.
    Bessac, L.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S210 - S211
12345